When: Tuesday, September 17, 2019, from 4:30 to 6 pm ET
Registration: Register - Opens in a new window for Medicare Learning Network events.
Signed into law in October 2018, the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act (SUPPORT ACT) outlines national strategies to help address opioid misuse. As part of Section 6065 of the SUPPORT Act, CMS is required to notify opioid prescribers with prescription patterns identified as “outliers” compared to their peers and encourage them to reference established opioid prescribing guidelines. CMS wants your input on how best to implement this provision of the SUPPORT Act.
Your feedback during this listening session will inform the CMS approach on the following topics:
- Methodology to establish outlier prescriber thresholds
- Tone and content of feedback reports to clinicians
- How to best identify a “medical specialty” from the National Provider Identifier framework
- How to define geographic areas for analysis
- Recommendations on opioid prescribing guidelines to include with the notification
CMS experts will ask these questions for your feedback:
- What information will be most useful to help you evaluate your opioid prescribing patterns and identify areas for improvement?
- How should CMS identify an “outlier prescriber” of opioids for notification?
- How should “medical specialty” be defined for the purpose of this analysis?
- What framework can be used to analyze opioid prescribing by specialty when nurse practitioners, other advanced practice nurses, and physician assistants have limited ability to designate a medical specialty area of practice?
- Understanding that state scope of practice laws impact opioid prescribing, should the analysis be performed at the state level?
- How can CMS present opioid prescribing data to clinicians in a way that will be well received and helpful?
- What are the best sources of information to share on pain management and opioid prescribing?
Target Audience: All prescribing clinicians.
For More Information: